Medicus Pharma Ltd. (MDCXW)
NCM
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Peers in industry
Medicus Pharma Ltd. has no peer companies in this window.
Recent press releases
April 2026
MDCXW voters approve consolidation amid material control weaknesses
# 📜 What This Document Is 📄 This document is a Preliminary Proxy Statement (PRE 14A), which is essentially a detailed instruction manual and informational pamphlet for Medicus Pharma Ltd.'s upcoming Annual General and Special Meeting of Shareholders. 📄 These proxy statements are required by the
SEC filings
All filings →Insider trades
All insider trades →Medicus Pharma Ltd. has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at Medicus Pharma Ltd.
All people →No officers or directors have been indexed for Medicus Pharma Ltd..